Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. R1 RCM Inc.
  6. Summary
    RCM   US7493971052

R1 RCM INC.

(RCM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
22.8(c) 22.76(c) 22.15(c) 21.94(c) 21.74 Last
875 223 539 792 1 287 494 574 351 727 804 Volume
+2.06% -0.18% -2.68% -0.95% -0.91% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 467 M - -
Net income 2021 112 M - -
Net Debt 2021 626 M - -
P/E ratio 2021 -21,8x
Yield 2021 -
Sales 2022 1 688 M - -
Net income 2022 167 M - -
Net Debt 2022 650 M - -
P/E ratio 2022 46,3x
Yield 2022 -
Capitalization 6 063 M 6 063 M -
EV / Sales 2021 4,56x
EV / Sales 2022 3,98x
Nbr of Employees 19 600
Free-Float 46,1%
More Financials
Company
R1 RCM Inc. is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. The Company's services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of end-to-end RCM services... 
More about the company
Ratings of R1 RCM Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about R1 RCM INC.
10/25R1 RCM : American Physician Partners Announces Revenue Cycle Partnership Extension with R1..
AQ
10/25American Physician Partners Announces Revenue Cycle Management Partnership Extension wi..
CI
10/14INSIDER SELL : R1 Rcm
MT
10/14R1 RCM : JPMorgan Starts R1 RCM at Overweight with $27 Price Target
MT
10/12R1 RCM : to Release Third Quarter 2021 Results on November 2
AQ
09/30R1 RCM : Barclays Starts R1 RCM at Overweight With $28 Price Target
MT
08/31R1 RCM : to Present at Upcoming Investor Conferences
AQ
08/12R1 RCM : Announces Appointment of Agnes Bundy Scanlan to Board of Directors (Form 8-K)
PU
08/12R1 RCM INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
AQ
08/12R1 RCM : Announces Appointment of Agnes Bundy Scanlan to Board of Directors
AQ
08/12R1 RCM Inc. Announces Appointment of Agnes Bundy Scanlan to its Board of Directors
CI
08/09R1 RCM : Introduces Entri™ Platform to Comprehensively Transform Patient Access and ..
AQ
08/09R1 RCM Inc. Introduces R1 EntriÖ Platform to Comprehensively Transform Patient Access a..
CI
08/03R1 RCM : Q2 Earnings Double as Revenue Improves, Company Lifts Full-Year Revenue Guidance
MT
08/03R1 RCM : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
More news
News in other languages on R1 RCM INC.

- No features available -

More news
Analyst Recommendations on R1 RCM INC.
More recommendations
Chart R1 RCM INC.
Duration : Period :
R1 RCM Inc. Technical Analysis Chart | RCM | US7493971052 | MarketScreener
Technical analysis trends R1 RCM INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 21,74 $
Average target price 31,90 $
Spread / Average Target 46,7%
EPS Revisions
Managers and Directors
Joseph Gerard Flanagan President, Chief Executive Officer & Director
Rachel Wilson Chief Financial Officer, Treasurer & Executive VP
Jay Sreedharan Chief Technology & Digital Officer
Julia K. Davis Chief Information Officer & Executive VP
John Sparby COO, Executive VP-Operations & Delivery
Sector and Competitors